Yubo International Biotech annual operating income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Yubo International Biotech Operating Income Growth & History (YBGJ)
Yubo International Biotech's operating income was −$1.2M for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$1.2M | $582,223 | — |
| 2024 | 2024-12-31 | −$1.8M | −$575,213 | — |
| 2023 | 2023-12-31 | −$1.2M | $10,517 | — |
| 2022 | 2022-12-31 | −$1.2M | $337,642 | — |
| 2021 | 2021-12-31 | −$1.5M | −$831,067 | — |
| 2020 · Dec 31 | 2020-12-31 | −$711,798 | — | — |
| 2020 · Feb 29 | 2020-02-29 | −$29,000 | $19,000 | — |
| 2019 | 2019-02-28 | −$48,000 | $10,000 | — |
| 2018 | 2018-02-28 | −$58,000 | $91,000 | — |
| 2017 | 2017-02-28 | −$149,000 | −$86,000 | — |
| 2016 | 2016-02-29 | −$63,000 | −$5,000 | — |
| 2015 | 2015-02-28 | −$58,000 | −$3,000 | — |
| 2014 | 2014-02-28 | −$55,000 | $5,000 | — |
| 2013 | 2013-02-28 | −$60,000 | −$13,000 | — |
| 2012 | 2012-02-29 | −$47,000 | $33,000 | — |
| 2011 | 2011-02-28 | −$80,000 | — | — |
Yubo International Biotech quarterly operating income
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.20
Q1.21
Q1.21
Q2.21
Q2.21
Q3.21
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$238,860 | $10,839 | — |
| Q1 2026 | 2026-03-31 | −$289,274 | $178,025 | — |
| Q4 2025 | 2025-12-31 | −$160,564 | $196,734 | — |
| Q3 2025 | 2025-09-30 | −$310,134 | $222,630 | — |
| Q2 2025 | 2025-06-30 | −$249,699 | $220,737 | — |
| Q1 2025 | 2025-03-31 | −$467,299 | −$57,878 | — |
| Q4 2024 | 2024-12-31 | −$357,298 | $160,023 | — |
| Q3 2024 | 2024-09-30 | −$532,764 | −$539,187 | — |
| Q2 2024 | 2024-06-30 | −$470,436 | −$103,160 | — |
| Q1 2024 | 2024-03-31 | −$409,421 | −$92,889 | — |
| Q4 2023 | 2023-12-31 | −$517,321 | −$620,803 | — |
| Q3 2023 | 2023-09-30 | $6,423 | $244,693 | — |
| Q2 2023 | 2023-06-30 | −$367,276 | $124,224 | — |
| Q1 2023 | 2023-03-31 | −$316,532 | $262,403 | — |
| Q4 2022 | 2022-12-31 | $103,482 | $491,678 | — |
| Q3 2022 | 2022-09-30 | −$238,270 | $107,744 | — |
| Q2 2022 | 2022-06-30 | −$491,500 | −$121,415 | — |
| Q1 2022 | 2022-03-31 | −$578,935 | −$140,365 | — |
| Q4 2021 | 2021-12-31 | −$388,196 | — | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −$346,014 | −$41,549 | — |
| Q2 2021 · Jun 30 | 2021-06-30 | −$370,085 | −$338,003 | — |
| Q1 2021 · Mar 31 | 2021-03-31 | −$438,570 | −$297,668 | — |
| Q3 2021 · Nov 30 | 2020-11-30 | −$25,485 | −$17,485 | — |
| Q2 2021 · Sep 30 | 2020-09-30 | −$304,465 | — | — |
| Q2 2021 · Aug 31 | 2020-08-31 | −$21,000 | −$13,000 | — |
| Q1 2021 · Jun 30 | 2020-06-30 | −$32,082 | — | — |
| Q1 2021 · May 31 | 2020-05-31 | −$7,000 | $1,000 | — |
| Q1 2020 · Mar 31 | 2020-03-31 | −$140,902 | — | — |
| Q4 2020 | 2020-02-29 | −$5,000 | $3,000 | — |
| Q3 2020 | 2019-11-30 | −$8,000 | −$1,000 | — |
| Q2 2020 | 2019-08-31 | −$8,000 | $4,000 | — |
| Q1 2020 · May 31 | 2019-05-31 | −$8,000 | $13,000 | — |
| Q4 2019 | 2019-02-28 | −$8,000 | −$17,000 | — |
| Q3 2019 | 2018-11-30 | −$7,000 | $15,000 | — |
| Q2 2019 | 2018-08-31 | −$12,000 | $10,000 | — |
| Q1 2019 | 2018-05-31 | −$21,000 | $2,000 | — |
| Q4 2018 | 2018-02-28 | $9,000 | $104,000 | — |
| Q3 2018 | 2017-11-30 | −$22,000 | $2,000 | — |
| Q2 2018 | 2017-08-31 | −$22,000 | −$8,000 | — |
| Q1 2018 | 2017-05-31 | −$23,000 | −$7,000 | — |
| Q4 2017 | 2017-02-28 | −$95,000 | −$82,000 | — |
| Q3 2017 | 2016-11-30 | −$24,000 | −$10,000 | — |
| Q2 2017 | 2016-08-31 | −$14,000 | $7,000 | — |
| Q1 2017 | 2016-05-31 | −$16,000 | −$1,000 | — |
| Q4 2016 | 2016-02-29 | −$13,000 | −$1,000 | — |
| Q3 2016 | 2015-11-30 | −$14,000 | $3,000 | — |
| Q2 2016 | 2015-08-31 | −$21,000 | −$7,000 | — |
| Q1 2016 | 2015-05-31 | −$15,000 | $0 | — |
| Q4 2015 | 2015-02-28 | −$12,000 | $2,000 | — |
| Q3 2015 | 2014-11-30 | −$17,000 | −$3,000 | — |
| Q2 2015 | 2014-08-31 | −$14,000 | $0 | — |
| Q1 2015 | 2014-05-31 | −$15,000 | −$2,000 | — |
| Q4 2014 | 2014-02-28 | −$14,000 | $0 | — |
| Q3 2014 | 2013-11-30 | −$14,000 | $5,000 | — |
| Q2 2014 | 2013-08-31 | −$14,000 | $0 | — |
| Q1 2014 | 2013-05-31 | −$13,000 | $0 | — |
| Q4 2013 | 2013-02-28 | −$14,000 | −$5,000 | — |
| Q3 2013 | 2012-11-30 | −$19,000 | −$6,000 | — |
| Q2 2013 | 2012-08-31 | −$14,000 | −$3,000 | — |
| Q1 2013 | 2012-05-31 | −$13,000 | $1,000 | — |
| Q4 2012 | 2012-02-29 | −$9,000 | — | — |
| Q3 2012 | 2011-11-30 | −$13,000 | $0 | — |
| Q2 2012 | 2011-08-31 | −$11,000 | — | — |
| Q1 2012 | 2011-05-31 | −$14,000 | — | — |
| Q3 2011 | 2010-11-30 | −$13,000 | — | — |
Yubo International Biotech operating income trends
Over the last five fiscal years, Yubo International Biotech's operating income decreased from −$711,798 to −$1.2M, a change of −$475,898. The latest reported quarter, Q2 2026, shows −$238,860.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗